Search

everythinglearnresearchcommunity

for

Search:↓

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

The polyherbal emulgel is a promising treatment for rheumatoid arthritis with effective and sustained results.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Lokivetmab reduced itching in a dog with skin lymphoma.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

The treatment cleared psoriasis in some patients but caused side effects in most.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

TNF-alpha inhibitors can cause various immune-related skin issues.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.